refractory metastatic colorectal cancer

Related by string. * Refractory : relapsed refractory multiple myeloma . refractory Hodgkin lymphoma . hormone refractory prostate cancer / Metastatic : metastatic prostate cancer . metastatic pancreatic cancer / colo rectal . Colorectal : metastatic colorectal cancer . colorectal cancer screenings / CANCER . www.cancer : San Antonio Breast Cancer . American Cancer Society * *

Related by context. Frequent words. (Click for all words.) 72 relapsed refractory multiple myeloma 71 relapsed multiple myeloma 68 refractory multiple myeloma 66 Taxotere ® 66 dacarbazine 66 TORISEL 66 B CLL 65 refractory Hodgkin lymphoma 65 Pivotal Phase III 65 metastatic renal cell carcinoma 65 Taxotere R 64 mCRC 64 TELCYTA 64 secondary hyperparathyroidism 64 Phenoptin 64 plus gemcitabine 64 plus prednisone 63 relapsed refractory 63 Torisel 63 Nexavar ® 63 axitinib 63 REPLAGAL 63 biologic therapy 63 phase IIb 63 tanespimycin 63 cutaneous T cell 63 TREANDA 63 diabetic neuropathic pain 63 HRPC 63 registrational 63 active comparator 63 Phase IIb clinical 63 Jevtana 63 HER2 positive metastatic breast 63 valopicitabine 63 Phase 2b clinical 62 lupus nephritis 62 metastatic colorectal cancer 62 confirmatory Phase III 62 nab paclitaxel 62 Gemcitabine 62 vinorelbine 62 Lenalidomide 62 pancreatic insufficiency 62 Irinotecan 62 Icatibant 62 refractory PTCL 62 Acute Myeloid Leukemia AML 62 Eloxatin R 62 PegIntron 62 resistant ovarian cancer 62 Phase Ib 62 azacitidine 62 Pirfenidone 62 FOLFIRI 62 Phase IIa trial 61 SUTENT 61 FIRAZYR 61 randomized Phase III 61 Erlotinib 61 Ventavis 61 androgen independent 61 Bevacizumab 61 ofatumumab 61 advanced NSCLC 61 myelodysplastic syndromes 61 FOLOTYN 61 lymphoma CTCL 61 diagnosed multiple myeloma 61 temsirolimus 61 unresectable 61 Azedra 61 malignant pleural mesothelioma 61 chronic lymphocytic leukemia CLL 60 injectable formulation 60 Phase 1b clinical 60 hormone refractory prostate cancer 60 Naglazyme 60 NSCLC 60 Phase IIb trial 60 gastrointestinal stromal tumors 60 Pivotal Phase 60 Everolimus 60 Alemtuzumab 60 TASQ 60 GI GVHD 60 temozolomide 60 anti TNF alpha 60 Trastuzumab 60 glufosfamide 60 angiogenesis inhibitor 60 romiplostim 60 relapsing forms 60 decitabine 60 hepatitis C HCV 60 Laquinimod 60 Nimotuzumab 60 recurrent ovarian cancer 60 sunitinib 60 Avastin bevacizumab 60 double blinded placebo

Back to home page